Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis

World Journal of Gastroenterology

Volumn 19, Issue 8, 2013, Pages 1271-1277

  Badawy, Ahmed Abouelkhair ^a   Zaher, Tarik Ibrahim ^a   Sharaf, Samar Mahmoud ^b   Emara, Mohamed Hassan ^a   Shaheen, Noha Elsaid ^a   Aly, Talaat Fathy ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Ascitic polymorphonuclear count; Cefotaxime; Cirrhosis; Levofloxacin; Meropenem; Spontaneous bacterial peritonitis

Indexed keywords

ALBUMIN; AMPICILLIN; BILIRUBIN; CEFOTAXIME; CREATININE; GLUCOSE; LACTATE DEHYDROGENASE; LEVOFLOXACIN; MEROPENEM; POTASSIUM; PROTEIN; SODIUM; SULBACTAM; UREA; VANCOMYCIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PROSPECTIVE STUDY; THROMBOCYTE; TREATMENT OUTCOME;

EID: 84874590388     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i8.1271     Document Type: Article

References (26)

1. Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J. Cefotaxime is more effective than is ampicillintobramycin in cirrhotics with severe infections. Hepatology 1985; 5: 457-462 [PMID: 3888810]
2. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417 [PMID: 20633946]
3. Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World J Gastroenterol 2009; 15: 3845-3850 [PMID: 19701963]
4. Umgelter A, Reindl W, Miedaner M, Schmid RM, Huber W. Failure of current antibiotic firstline regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection 2009; 37: 2-8 [PMID: 19169633]
5. Ariza X, Castellote J, Lora-Tamayo J, Girbau A, Salord S, Rota R, Ariza J, Xiol X. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol 2012; 56: 825-832 [PMID: 22173153]
6. Horinek E, Fish D. Spontaneous bacterial peritonitis. AACN Adv Crit Care 2009; 20: 121-125; quiz 127 [PMID: 19411866]
7. Heo J, Seo YS, Yim HJ, Hahn T, Park SH, Ahn SH, Park JY, Park JY, Kim MY, Park SK, Cho M, Um SH, Han KH, Kim HS, Baik SK, Kim BI, Cho SH. Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study. Gut Liver 2009; 3: 197-204 [PMID: 20431746]
8. Pfaller MA, Jones RN. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide. Diagn Microbiol Infect Dis 1997; 28: 157-163 [PMID: 9327242]
9. Ahmad M, Ali AA, Mumtaz M, Iqbal J, Mughal AA. Spontaneous bacterial peritonitis; Microbiological analysis of ascitic fluid in patients with complicated liver cirrhosis. Professional Med J Jan 2011; 18: 557-561
10. El-Bendary MM, Abdel-Aziz M, El-Sherbiny WA, Farag RE, El-Gilany A, Zaghloul MH. Spontaneous bacterial peritonitis: clinicoepidemiological and microbiological study. Benha Med J 2009; 26: 287-306
11. Yakar T, Güçlü M, Serin E, Alişkan H, Husamettin E. A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis. Dig Dis Sci 2010; 55: 1149-1154 [PMID: 19424797]
12. Angeloni S, Leboffe C, Parente A, Venditti M, Giordano A, Merli M, Riggio O. Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice. World J Gastroenterol 2008; 14: 2757-2762 [PMID: 18461661]
13. Sun L, Zhang JV, Zhao J, Bai WT, Huang CX, Jia ZS, Lian JQ, Sun YT. Changes in the profiles of bacteria causing spontaneous bacterial peritonitis: A recent twelveyear study. Afr J Microbiol Res 2010; 4: 527
14. Levison ME, Bush LM. Peritonitis and intraperitoneal abcesses. In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Elsevier, 2005: 927-951
15. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353: 139-142 [PMID: 10023916]
16. Bernard B, Grangé JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a metaanalysis. Hepatology 1999; 29: 1655-1661 [PMID: 10347104]
17. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42 [PMID: 18293275]
18. Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142-153 [PMID: 10673079]
19. Hoefs JC. Spontaneous bacterial peritonitis: prevention and therapy. Hepatology 1990; 12: 776-781 [PMID: 2210680]
20. Taşkiran B, Colakoǧlu O, Sözmen B, Unsal B, Aslan SL, Buyraç Z. Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis. Turk J Gastroenterol 2004; 15: 34-38 [PMID: 15264119]
21. Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-148 [PMID: 11786970]
22. Bert F, Noussair L, Lambert-Zechovsky N, Valla D. Viridans group streptococci: an underestimated cause of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Eur J Gastroenterol Hepatol 2005; 17: 929-933 [PMID: 16093870]
23. Cormican MG, Runyon BA, Jones RN. In vitro activity of levofloxacin and FK-037 against aerobic isolates from spontaneous bacterial peritonitis. J Chemother 1995; 7: 197-200 [PMID: 7562013]
24. Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extendedspectrum betalactamases (ESBLs). Clin Microbiol Infect 2000; 6: 460-463 [PMID: 11168179]
25. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruizdel-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginès P, Rodés J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-409 [PMID: 10432325]
26. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-1318 [PMID: 17389705 DOI: 10.1136/gut.2006.107789]